These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3720211)

  • 1. Postinfusion phlebitis associated with a syringe system versus minibags.
    Rapp RP; Powers P; Tolbert V; Piecoro JJ; Record KE
    Clin Pharm; 1986 May; 5(5):408-11. PubMed ID: 3720211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infusion phlebitis associated with a programmable syringe-pump system versus gravity-feed minibottles.
    Baptista RJ; Driscoll DF; Gallagher JA; O'Keefe E; Dumas GJ; Hammer SM; Pacella PP
    Clin Pharm; 1987 Apr; 6(4):314-8. PubMed ID: 3665384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postinfusion phlebitis after intravenous push versus intravenous piggyback administration of antimicrobial agents.
    Garrelts JC; Ast D; LaRocca J; Smith DF; Peterie JD
    Clin Pharm; 1988 Oct; 7(10):760-5. PubMed ID: 3233896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inline filtration on postinfusion phlebitis.
    Maddox RR; John JF; Brown LL; Smith CE
    Clin Pharm; 1983; 2(1):58-61. PubMed ID: 6883931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices.
    Hamilton RA; Plis JM; Clay C; Sylvan L
    Clin Pharm; 1988 Jun; 7(6):439-43. PubMed ID: 3402178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inline filtration of intravenous infusions on the incidence of thrombophlebitis.
    Chamberland ME; Lyons RW; Brock SM
    Am J Hosp Pharm; 1977 Oct; 34(10):1068-70. PubMed ID: 920740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of gentamicin by a controlled-release infusion system versus a minibag system.
    Munoz DM; Green ER; Chrymko MM; Mylotte JM; Kitrenos JG
    Clin Pharm; 1988 Apr; 7(4):303-7. PubMed ID: 3365924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of heparin and 0.9% sodium chloride injection in the maintenance of indwelling intermittent i.v. devices.
    Garrelts JC; LaRocca J; Ast D; Smith DF; Sweet DE
    Clin Pharm; 1989 Jan; 8(1):34-9. PubMed ID: 2643500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of 0.9% sodium chloride injection with and without heparin for maintaining indwelling intermittent injection sites.
    Epperson EL
    Clin Pharm; 1984; 3(6):626-9. PubMed ID: 6509875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filtration and infusion phlebitis: a double-blind prospective clinical study.
    DeLuca PP; Rapp RP; Bivins B; McKean HE; Griffen WO
    Am J Hosp Pharm; 1975 Oct; 32(10):1001-7. PubMed ID: 1103617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between incidence of phlebitis and frequency of changing IV tubing and percutaneous site.
    Nichols EG; Barstow RE; Cooper D
    Nurs Res; 1983; 32(4):247-52. PubMed ID: 6553250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind study to investigate methods to prevent cephalothin-induced phlebitis.
    Maddox RR; Rush DR; Rapp RP; Foster TS; Mazella V; McKean HE
    Am J Hosp Pharm; 1977 Jan; 34(1):29-34. PubMed ID: 831472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation and cost analysis of a syringe pump system for intermittent i.v. drug delivery.
    Colangelo A; Clark ST; Janousek JP
    Am J Hosp Pharm; 1985 Mar; 42(3):581-4. PubMed ID: 3985021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing superficial phlebitis during infusion of crystalloid solutions in surgical patients.
    Bass J; Freeman JB; Makarewicz P; Sproule P; Fairfull-Smith R
    Can J Surg; 1985 Mar; 28(2):124-5. PubMed ID: 3971235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral vein complications in patients receiving amino acid/dextrose solutions.
    Massar EL; Daly JM; Copeland EM; Johnson DE; VonEshenbach AC; Johnston D; Rundell B; Dudrick SJ
    JPEN J Parenter Enteral Nutr; 1983; 7(2):159-62. PubMed ID: 6406705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral intravenous therapy-related phlebitis rates in an adult population.
    White SA
    J Intraven Nurs; 2001; 24(1):19-24. PubMed ID: 11836840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osmolality of small-volume intravenous admixtures.
    Wermeling DP; Rapp RP; DeLuca PP; Piecoro JJ
    Am J Hosp Pharm; 1985 Aug; 42(8):1739-44. PubMed ID: 4036971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infusion-related phlebitis.
    Danchaivijitr S; Srihapol N; Pakaworawuth S; Vaithayapiches S; Judang T; Pumsuwan V; Kachintorn K
    J Med Assoc Thai; 1995 Jul; 78 Suppl 2():S85-90. PubMed ID: 7561602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of intravenous catheter-associated phlebitis.
    Hershey CO; Tomford JW; McLaren CE; Porter DK; Cohen DI
    Arch Intern Med; 1984 Jul; 144(7):1373-5. PubMed ID: 6732398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis against postinfusion phlebitis.
    Fonkalsrud EW; Carpenter K; Masuda JY; Beckerman JH
    Surg Gynecol Obstet; 1971 Aug; 133(2):253-6. PubMed ID: 5565353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.